tiprankstipranks
Trending News
More News >
Assicurazioni Generali (ARZGY)
OTHER OTC:ARZGY
Advertisement

Assicurazioni Generali (ARZGY) AI Stock Analysis

Compare
38 Followers

Top Page

ARZGY

Assicurazioni Generali

(OTC:ARZGY)

Select Model
Select Model
Select Model
Outperform 75 (OpenAI - 4o)
Rating:75Outperform
Price Target:
$22.00
▲(11.28% Upside)
Assicurazioni Generali's overall stock score reflects a stable financial position with strong profitability and efficient operations. The positive technical indicators and solid earnings call performance further bolster the score. Valuation metrics are reasonable, providing a balanced outlook. Challenges such as potential restructuring charges and cash flow variability are noted but do not significantly detract from the overall positive assessment.
Positive Factors
Technological Advancements
Generali's advancements in technology enhance operational efficiency and risk management, strengthening its competitive position long-term.
Stable Solvency Ratio
A stable solvency ratio indicates strong capital management, ensuring financial stability and resilience against market fluctuations.
Growth in Life Business
Significant inflows in the Life segment reflect robust demand and effective product offerings, supporting long-term revenue growth.
Negative Factors
Revenue Decline
Declining revenue trends may pressure profitability and limit growth opportunities, necessitating strategic adjustments to sustain performance.
Potential Restructuring Charges
Anticipated restructuring charges could impact net results, signaling potential operational challenges and cost management issues.
Negative Operating Variances
Negative variances in the Life segment suggest regulatory and operational hurdles, potentially affecting future profitability and stability.

Assicurazioni Generali (ARZGY) vs. SPDR S&P 500 ETF (SPY)

Assicurazioni Generali Business Overview & Revenue Model

Company DescriptionAssicurazioni Generali S.p.A. provides various insurance solutions. The company operates through four segments: Non-Life; Life; Asset Management; and Holding and Other Business. It offers saving and protection insurance products for individuals and family; unit linked products with investment purposes; and motor, motor third-party liability, casualty, accident, health, and commercial and industrial risks insurance products. The company also provides equity and fixed-income funds, and alternative products; and investment advisory, asset management, and financial planning services. It operates in Italy, France, Germany, Austria, Czech Republic, Poland, Hungary, Slovakia, Serbia, Montenegro, Romania, Slovenia, Bulgaria, Croatia, Russia, Spain, Switzerland, the Americas, Southern Europe, and Asia. The company was formerly known as Assicurazioni Generali Austro-Italiche and changed its name to Assicurazioni Generali S.p.A. in 1848. Assicurazioni Generali S.p.A. was founded in 1831 and is headquartered in Trieste, Italy.
How the Company Makes MoneyGenerali generates revenue primarily through the sale of insurance premiums in both life and non-life segments. The company collects premiums from policyholders, which serve as a core revenue stream. Additionally, Generali earns income from investment activities, as it manages a substantial portfolio of assets that includes stocks, bonds, and real estate. Investment income is a significant contributor to the company’s profitability, as it can yield returns that complement the funds generated from premiums. Furthermore, Generali engages in reinsurance and collaborates with various partners and intermediaries to expand its reach and market presence. The company also benefits from economies of scale and diversified operations across different regions, which help mitigate risks and enhance overall earnings.

Assicurazioni Generali Earnings Call Summary

Earnings Call Date:Nov 13, 2025
(Q3-2025)
|
% Change Since: |
Next Earnings Date:Mar 12, 2026
Earnings Call Sentiment Neutral
The earnings call presented a strong performance in the P&C and Life businesses, with significant advancements in technology and stable solvency. However, challenges such as potential restructuring charges, internal model loss in Spain, and negative operating variances in the Life CSM were noted. The overall sentiment is balanced, considering both the positive financial performance and the upcoming challenges.
Q3-2025 Updates
Positive Updates
Strong Performance in P&C Business
P&C business showed positive momentum with top-line growth over 7% and margin expansion, with the undiscounted combined ratio improving by over 2 percentage points compared to last year.
Growth in Life Business
Life net inflow exceeded EUR 10 billion at 9 months, with significant contributions from Protection & Health (EUR 3.7 billion) and hybrid and unit-linked (EUR 4.7 billion).
Improvement in New Business Margin
New business margin guidance was between 5.25% and 5.75%, achieving 5.74% in the current quarter, demonstrating strong performance in both volume and margin.
Stable Solvency Ratio
The group solvency ratio remains solid at 214%, with healthy normalized capital generation and including the EUR 500 million share buyback program.
Advancements in Technology
Developments in Nat Cat modeling, claims automation, and geospatial platform have been highlighted, showcasing technological advancements and improvements in efficiency.
Negative Updates
Impact of Spain Internal Model Loss
Temporary loss of the internal model application for Spain as part of the Liberty integration, with a reverse merger impact of around minus 4 percentage points on the solvency ratio, expected to revert in 2027.
Potential Restructuring Charges
Expected additional restructuring charges in the fourth quarter, which may impact the adjusted net result.
Negative Operating Variances in Life CSM
Operating variances in the Life CSM due to a tax regulation change in Germany and model refinements, leading to negative operating variances of around EUR 200 million.
Impact of France Downgrade
Rating downgrade of the Republic of France expected to reduce group solvency ratio by almost 1 percentage point.
Company Guidance
During the Generali Group's 9-month 2025 results presentation, key financial metrics highlighted include a P&C top line increase of over 7% and an improvement in the undiscounted combined ratio by more than 2 percentage points compared to the previous year. The company also reported a significant pricing effect with a 6.4% increase for motor and a 5.2% improvement for non-motor retail and SME segments. In the Life segment, Generali achieved over €10 billion in net inflows, with €3.7 billion from Protection & Health and €4.7 billion from hybrid and unit-linked products. The new business margin improved to 5.74%, nearing its 2027 target. On the capital side, the group maintained a solid solvency ratio of 214% as of November 10, 2025, despite anticipated impacts from acquisitions and regulatory changes. The group's strategic initiatives are driving operational efficiencies and disciplined underwriting, contributing to an EPS growth of 16% year-on-year and positioning Generali to potentially exceed its Lifetime Partner 27 driving excellence plan targets.

Assicurazioni Generali Financial Statement Overview

Summary
Assicurazioni Generali presents a stable financial position with strong profitability and efficient operations. While revenue trends show some decline, cost control measures maintain profitability. The balance sheet is well-managed with moderate leverage. Cash flows are solid, though variability in free cash flow growth suggests the need for ongoing monitoring.
Income Statement
72
Positive
Assicurazioni Generali demonstrates a solid revenue base with moderate growth. The gross profit margin is strong, indicating efficient cost management. However, there is a noticeable decline in revenue over the past years, impacting net profit margins. EBIT and EBITDA margins are robust, reflecting good operational efficiency.
Balance Sheet
78
Positive
The company maintains a healthy equity position, with a strong equity ratio. The debt-to-equity ratio shows moderate leverage, which is typical for the insurance industry. Return on equity is stable, suggesting consistent profitability. Overall, the balance sheet reflects financial stability.
Cash Flow
67
Positive
Operating cash flow remains positive, indicating good cash generation from core operations. However, fluctuations in free cash flow growth and a moderate free cash flow to net income ratio suggest potential variability in cash flow management. The cash flow statement reflects strong operational cash generation but highlights the need for careful capital expenditure management.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue53.39B55.30B53.73B50.48B95.67B77.72B
Gross Profit53.39B55.30B48.48B0.0095.67B81.03B
EBITDA8.01B7.19B112.82B4.58B6.09B5.06B
Net Income3.82B3.72B3.75B2.35B2.85B1.74B
Balance Sheet
Total Assets542.04B538.65B508.61B519.05B586.23B544.71B
Cash, Cash Equivalents and Short-Term Investments0.00246.29B230.43B287.67B357.05B344.90B
Total Debt38.65B17.58B33.17B16.48B16.57B13.42B
Total Liabilities509.77B505.55B477.33B500.91B554.35B512.92B
Stockholders Equity29.72B30.39B28.97B26.65B29.31B30.03B
Cash Flow
Free Cash Flow19.12B16.41B1.55B9.90B29.39B19.01B
Operating Cash Flow19.64B16.82B1.73B10.54B17.48B19.34B
Investing Cash Flow-18.17B-15.12B2.28B-9.02B-16.30B-15.98B
Financing Cash Flow-363.80M-369.94M-3.80B-2.42B-677.00M-2.27B

Assicurazioni Generali Technical Analysis

Technical Analysis Sentiment
Positive
Last Price19.77
Price Trends
50DMA
19.26
Positive
100DMA
19.25
Positive
200DMA
18.38
Positive
Market Momentum
MACD
0.15
Negative
RSI
57.11
Neutral
STOCH
85.78
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For ARZGY, the sentiment is Positive. The current price of 19.77 is above the 20-day moving average (MA) of 19.38, above the 50-day MA of 19.26, and above the 200-day MA of 18.38, indicating a bullish trend. The MACD of 0.15 indicates Negative momentum. The RSI at 57.11 is Neutral, neither overbought nor oversold. The STOCH value of 85.78 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for ARZGY.

Assicurazioni Generali Peers Comparison

Overall Rating
UnderperformOutperform
Sector (68)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
82
Outperform
$37.65B11.0420.07%1.62%7.11%22.52%
79
Outperform
$33.61B8.6717.81%16.68%-28.54%
76
Outperform
$18.52B12.2813.74%3.62%12.33%
75
Outperform
$61.03B14.5512.68%4.08%-0.06%9.93%
69
Neutral
$12.60B8.7614.42%5.62%-6.19%
68
Neutral
$18.00B11.429.92%3.81%9.73%1.22%
59
Neutral
$41.34B13.737.68%2.21%-23.02%52.43%
* Financial Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
ARZGY
Assicurazioni Generali
19.77
5.52
38.77%
AEG
Aegon
7.86
1.67
26.98%
AIG
American International Group
77.07
2.72
3.66%
ACGL
Arch Capital Group
92.72
-5.76
-5.85%
HIG
Hartford Insurance
133.04
14.44
12.18%
PFG
Principal Financial
85.94
4.27
5.23%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Nov 13, 2025